Category
Baricitinib
CAS Number
1146629-77-7
Molecular Formula
C₁₅H₁₇N₅O₂
Molecular Weight
299.33 g/mol
Synonym

[4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate ; [4-(1H-Pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate;Propanoic acid, 2,2-dimethyl-, [4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl ester

Keywords
Intermediates
Impurities
Impurities manufacturer and Suppliers in Hyderabad india
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

The compound (4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate is a chemical intermediate or derivative associated with Baricitinib. It features a pyrazole and pyrrolopyrimidine core linked to a pivalate ester group, and is typically involved in the synthesis or impurity profile of Baricitinib, monitored to ensure purity and control of unwanted byproducts.